Article info

Download PDFPDF
Combined therapy of cyclosporine A and mycophenolate mofetil for the treatment of birdshot retinochoroidopathy: a 12-month follow-up

Authors

  • Rene Antonio Cervantes-Castañeda Massachusetts Eye Research and Surgery Institution, Cambridge, Massachusetts, USA CODET Vision Institute, Ocular Inflammatory Disease Department, Tijuana, Mexico PubMed articlesGoogle scholar articles
  • Luis Alonso Gonzalez-Gonzalez Massachusetts Eye Research and Surgery Institution, Cambridge, Massachusetts, USA Ocular Immunology and Uveitis Foundation, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Miguel Cordero-Coma Massachusetts Eye Research and Surgery Institution, Cambridge, Massachusetts, USA Uveitis Unit, Department of Ophthalmology, Hospital de Leon, León, Spain PubMed articlesGoogle scholar articles
  • Taygan Yilmaz Massachusetts Eye Research and Surgery Institution, Cambridge, Massachusetts, USA Stony Brook Medical Center, New York, New York, USA PubMed articlesGoogle scholar articles
  • C Stephen Foster Massachusetts Eye Research and Surgery Institution, Cambridge, Massachusetts, USA Ocular Immunology and Uveitis Foundation, Cambridge, Massachusetts, USA Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr C Stephen Foster, Massachusetts Eye Research and Surgery Institution, 5 Cambridge Center, 8th Floor, Cambridge, MA 02142, USA; fosters{at}uveitis.org
View Full Text

Citation

Cervantes-Castañeda RA, Gonzalez-Gonzalez LA, Cordero-Coma M, et al
Combined therapy of cyclosporine A and mycophenolate mofetil for the treatment of birdshot retinochoroidopathy: a 12-month follow-up

Publication history

  • Received May 31, 2012
  • Revised January 4, 2013
  • Accepted January 30, 2013
  • First published February 22, 2013.
Online issue publication 
March 22, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.